News & Updates
Filter by Specialty:
Solithromycin safe, effective in paediatric community-acquired bacterial pneumonia
Treatment with intravenous or oral solithromycin is well-tolerated and leads to clinical improvement in most children and adolescents with community-acquired bacterial pneumonia (CABP), results of a recent study have shown.
Solithromycin safe, effective in paediatric community-acquired bacterial pneumonia
12 Jul 2022Clinical anxiety common in children with autism spectrum disorders
Children with autism spectrum disorders (ASD) are highly likely to suffer from clinical-level anxiety, a recent study has found. ASD severity and sensory processing difficulties appear to aggravate anxiety in this population.
Clinical anxiety common in children with autism spectrum disorders
11 Jul 2022Systematic endotracheal aspiration cuts antibiotic use for ventilator-related pneumonia
Being aware of bronchial colonization results in a decreased use of initial broad-spectrum antibiotic for ventilator-associated pneumonia (VAP) in the paediatric intensive care unit (PICU), reports a recent study.
Systematic endotracheal aspiration cuts antibiotic use for ventilator-related pneumonia
11 Jul 2022Is extended superior to standard antibiotic course in children hospitalized with CAP?
An extended antibiotic course appears to be not any better than a standard course at achieving clinical cure among children hospitalized with community-acquired pneumonia (CAP) and at risk of chronic respiratory illnesses at 4 weeks, a study has shown.
Is extended superior to standard antibiotic course in children hospitalized with CAP?
11 Jul 2022Tear film breakup time tied to choroidal thickness, axial length in kids with DED
In children with dry eye disease (DED) symptoms, there appears to be a significant association between tear film breakup time and choroidal thickness, which in turn is correlated with axial length, a recent study has found.
Tear film breakup time tied to choroidal thickness, axial length in kids with DED
09 Jul 2022Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
Children with ulcerative colitis seem to respond well to vedolizumab in the first-line setting, inducing remission without increasing the risk of adverse events, according to a small study.